Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

Clinical Genetics - Tập 76 Số 1 - Trang 1-18 - 2009
Lynch Ht1, P. M. Lynch2, Stephen J. Lanspa3, Carrie Snyder1, Jane F. Lynch1, CR Boland4
1Department of Preventive Medicine, Creighton University, School of Medicine, Omaha, NE, USA
2Department of Gastroenterology, Hepatology & Nutrition, University of Texas MD Anderson Cancer Center, Houston TX, USA
3Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE, USA
4Department of Internal Medicine, Division of Gastroenterology, Baylor University Medical Center, Dallas TX, USA

Tóm tắt

More than one million patients will manifest colorectal cancer (CRC) this year of which, conservatively, approximately 3% (∼30,700 cases) will have Lynch syndrome (LS), the most common hereditary CRC predisposing syndrome. Each case belongs to a family with clinical needs that require genetic counseling, DNA testing for mismatch repair genes (most frequently MLH1 or MSH2) and screening for CRC. Colonoscopy is mandated, given CRC's proximal occurrence (70–80% proximal to the splenic flexure). Due to its early age of onset (average 45 years of age), colonoscopy needs to start by age 25, and because of its accelerated carcinogenesis, it should be repeated every 1 to 2 years through age 40 and then annually thereafter. Should CRC occur, subtotal colectomy may be necessary, given the marked frequency of synchronous and metachronous CRC. Because 40–60% of female patients will manifest endometrial cancer, tailored management is essential. Additional extracolonic cancers include ovary, stomach, small bowel, pancreas, hepatobiliary tract, upper uroepithelial tract, brain (Turcot variant) and sebaceous adenomas/carcinomas (Muir‐Torre variant). LS explains only 10–25% of familial CRC.

Từ khóa


Tài liệu tham khảo

International Agency for Research on Cancer.Globocan 2002. Available at:http://www‐dep.iarc.fr/.2008: accessed on: 25 November 2008.

10.1200/JCO.2008.17.5950

Bussey HJR., 1975, Familial polyposis coli: family studies, histopathology, differential diagnosis, and results of treatment

10.1007/BF00342466

10.1158/1078-0432.CCR-06-1256

10.1615/CritRevOncog.v14.i1.10

10.1016/S1568-7864(02)00081-2

10.1056/NEJMra012242

10.1038/sj.ejhg.5201584

10.1056/NEJMsb042979

United States Department of Health & Human Services.U.S. surgeon general's family history initiative. 12‐29‐2004. Available at:http://www.hhs.gov/familyhistory/.2009: accessed on: 28 January 2009.

10.1001/jama.296.12.1479

10.1001/jama.296.12.1507

10.1001/jama.296.12.1469

10.1001/jama.296.12.1521

10.1007/BF02360076

10.1016/S0140-6736(00)95996-8

10.1002/ajmg.1320250309

10.1038/328614a0

10.1001/jama.294.19.2465

Bussey HJR., 1990, Familial adenomatous polyposis, 1

10.1001/archinte.1913.00070050063006

10.1001/archinte.1966.03870080050009

10.1007/BF02053699

10.1016/S0016-5085(99)70510-X

10.1093/jnci/djh034

10.1126/science.8484120

10.1038/ng1193-279

10.1038/363558a0

10.1126/science.8484121

10.1126/science.8484122

10.1056/NEJMp038099

StrandM ProllaTA LiskayRMet al.Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair.365:274–276.

10.1016/0092-8674(93)90546-3

10.1016/0092-8674(93)90330-S

10.1038/368258a0

10.1126/science.8128251

10.1053/j.gastro.2004.03.068

10.1038/371075a0

10.1002/ijc.11218

10.1038/ng1001-137

10.1007/s10689-004-4489-x

Smith RA, American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers; Also: Update 2001—testing for early lung cancer detection, CA Cancer J Clin, 51, 38, 10.3322/canjclin.51.1.38

10.1007/s10350-004-7273-y

National Comprehensive Cancer Network.Practice guidelines in oncology. Available at:http://www.nccn.org/professionals/physician_gls/default.asp2008: Accessed on: 2 April 2008.

10.1053/gast.2003.50044

Lynch HT, 2006, Clinical selection of candidates for mutational testing for cancer susceptibility, Oncology, 20, 29

10.1038/nm0495-348

10.1001/jama.293.16.1979

Jass JR, 1994, Pathology of hereditary non‐polyposis colorectal cancer, Anticancer Res, 14, 1631

10.1111/j.1365-2559.2006.02549.x

Boland CR, 1998, A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res, 58, 5248

Kane MF, 1997, Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair‐defective human tumor cell lines, Cancer Res, 57, 808

Cunningham JM, 1998, Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability, Cancer Res, 58, 3455

10.1097/00000478-199910000-00010

10.1158/0008-5472.CAN-08-0002

10.1053/gast.2002.37070

10.1056/NEJM200001133420201

10.1056/NEJMoa022289

10.1007/s10689-004-1447-6

10.1007/s10689-007-9145-9

10.1074/jbc.M001140200

10.1007/s10689-004-7993-0

10.1053/j.gastro.2005.06.005

10.1158/0008-5472.CAN-06-1896

10.1016/j.gastro.2005.05.067

10.1007/s10350-008-9414-1

10.1038/labinvest.3780262

10.1200/JCO.2002.20.4.1043

10.1001/jama.293.7.799

10.1038/35002251

10.1053/j.gastro.2008.04.026

Ricciardone MD, 1999, Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type I, Cancer Res, 59, 290

10.1053/j.gastro.2003.11.008

10.1007/s10689-005-8351-6

10.1111/j.1399-0004.2007.00801.x

10.7326/0003-4819-100-5-700

10.1007/s00439-008-0542-4

Liu B, 1994, hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds, Cancer Res, 54, 4590

10.1136/jmg.32.5.352

10.1136/jmg.37.9.646

10.1056/NEJMoa043146

10.1007/s10350-004-6397-4

10.1038/nm1195-1203

Moisio A‐L, 1996, Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer, Am J Hum Genet, 1243

10.1086/345075

10.1038/nrc1453

10.1086/373963

10.1002/humu.9171

10.1002/gcc.10094

10.1001/jama.291.6.718

10.1158/0008-5472.CAN-07-6599

10.1053/j.gastro.2008.09.033

10.1002/(SICI)1097-0142(19980715)83:2<259::AID-CNCR9>3.0.CO;2-L

10.1007/s10689-005-6573-2

10.1002/bies.950161110

Koi M, 1994, Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N‐methyl‐N’‐nitro‐N‐nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation, Cancer Res, 54, 4308

Hawn MT, 1995, Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint, Cancer Res, 55, 3721

10.1172/JCI118767

Aebi S, 1996, Loss of DNA mismatch repair in acquired resistance to cisplatin, Cancer Res, 56, 3087

10.1016/S0016-5085(99)70558-5

10.1016/S0140-6736(00)02261-3

10.1053/j.gastro.2003.12.023

10.1158/1078-0432.CCR-05-1030

10.1002/ijc.11712

10.1136/gut.2005.073015

Jacob S, 2001, The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells, Cancer Res, 61, 6555

Fallik D, 2003, Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer, Cancer Res, 63, 5738

10.1136/gut.42.5.673

Hamilton SR, 2000, Tumours of the digestive system

10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U

Brose MS, 2003, Cancer medicine, 241

10.1016/S0016-5085(00)70168-5

10.1016/S0140-6736(95)91016-6

10.1053/j.gastro.2007.08.019

10.1111/j.1572-0241.2005.41481.x

10.1053/j.gastro.2005.11.032

10.1136/gut.50.3.382

10.1007/s10620-007-0041-9

10.1016/S1542-3565(05)00403-9

10.1136/gut.2007.128926

10.1158/1940-6207.CAPR-08-0098

10.1093/hmg/6.1.105

10.1053/gast.1996.v110.pm8612988

10.1056/NEJMoa052627

10.1002/1097-0142(20010215)91:4<625::AID-CNCR1044>3.0.CO;2-4

10.1002/(SICI)1097-0215(20000120)89:1<44::AID-IJC8>3.0.CO;2-3

10.1158/1078-0432.CCR-08-0389

10.1086/426403

10.1038/sj.ejhg.5201734

10.1136/jmg.2005.038331

10.1002/path.1764

10.1056/NEJM199805213382101

10.1016/j.cgh.2007.10.011

10.1053/j.gastro.2008.02.094

10.1158/1078-0432.CCR-05-0965

10.1200/JCO.2006.06.9781

10.1158/1078-0432.CCR-06-2996

10.1056/NEJMp0803964

10.1053/j.seminoncol.2007.07.007

10.1001/jama.292.12.1469

Online Mendelian Inheritance in Man. McKusick‐Nathans Institute for Medical Genetics Johns Hopkins University (Baltimore MD) and National Center for Biotechnology Information National Library of Medicine (Bethesda MD). Available at:http://www.ncbi.nlm.nih.gov/omim.2008: accessed on: 25 November 2008.

10.1002/ijc.23508

10.1111/j.1399-0004.2008.01125.x

10.1093/jnci/djh280